Hormones and Bone Health: Evidence

Bone is a living tissue that is constantly broken down and rebuilt, and hormones are central to keeping that process in balance. This page summarizes, in plain language, what the broad body of evidence and major guidelines generally conclude about hormones and bone health.

What question links hormones and bone?

It is easy to picture bone as a fixed, inert scaffold, but it is closer to a tissue under constant renovation. Specialized cells continuously remove old bone while others lay down new bone, a process called remodeling. When removal and rebuilding stay balanced, bone strength is maintained; when removal outpaces rebuilding, bone gradually weakens and the risk of fracture rises. Hormones are among the most important regulators of that balance, which is why so many endocrine conditions and treatments have consequences for the skeleton.

Which hormones matter for bone

Several hormones influence bone. Estrogen plays a major role in maintaining bone density in both women and men, which is why bone loss tends to accelerate around menopause when estrogen falls. Testosterone also supports bone, partly through its conversion to estrogen. Thyroid hormone influences the pace of remodeling, and both too little and too much can affect bone over time. Parathyroid hormone and vitamin D (which acts in a hormone-like way) together regulate calcium balance, drawing on and depositing into the skeleton as needed. Excess cortisol, whether from disease or long-term steroid medication, is a well-recognized contributor to bone loss.

What the evidence broadly shows

The connection between estrogen decline and accelerated bone loss is well established, as is the link between certain hormone excesses or deficiencies and weaker bones. The body of evidence supports that adequate calcium and vitamin D, weight-bearing and muscle-strengthening activity, and avoiding modifiable risks such as smoking and excess alcohol all support bone health, and that correcting an underlying hormonal problem can help protect bone.

For people at high fracture risk, several treatment classes have strong trial evidence for reducing fractures — a point worth emphasizing, because fracture reduction, not just an improved scan number, is what matters to patients. Menopausal hormone therapy is recognized as effective for preserving bone density, though guidelines weigh that against its other risks and benefits rather than recommending it for bone protection alone.

How bone health is assessed

Bone density is commonly measured with a scan, and the result is interpreted alongside overall fracture-risk factors — such as age, prior fractures, family history, and certain medications — rather than in isolation. Tools that estimate fracture risk combine several of these factors. Hormone testing may be part of the picture when an underlying endocrine cause is suspected, for example when bone loss seems out of proportion to a person's age or other risks. Reference ranges and density scores are guides, not verdicts, and are read in context.

Hormonal conditions that affect bone

Beyond menopause, several endocrine situations are recognized as influencing bone. An overactive thyroid, or over-replacement with thyroid medication, can increase bone turnover. Overactivity of the parathyroid glands can draw calcium from bone. Long-term high cortisol, including from corticosteroid medication taken for other conditions, is a common and important cause of bone loss that clinicians actively monitor. Low sex-hormone levels in either men or women can contribute as well. In each case, the bone effect is one of several reasons these conditions are evaluated and managed carefully.

Where research is still developing

Open questions include the best long-term strategies for preserving bone after menopause, how to balance the bone benefits of hormone therapy against its other effects, the optimal role of hormone treatment in men with low testosterone and low bone density, and how best to combine lifestyle, nutrition, and medication over a lifetime. The relationship between specific lab numbers and an individual's true fracture risk is also an ongoing area of study, as is how best to sequence and combine the available fracture-reducing treatments.

What it means for patients

This is educational background, not personalized advice. The broad message of the evidence is that bone health reflects a lifelong interplay of hormones, nutrition, and activity, and that protecting bone usually involves addressing several factors rather than any single fix. Decisions about protecting bone depend on your individual risk factors, test results, and overall health, and should be made with a qualified clinician.

For related background, see our conditions, treatments, hormones, and blood tests sections, and other overviews in the studies index such as menopausal hormone therapy, testosterone therapy, and vitamin D and hormones.